NCT04567706Recruiting
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
Analysis of the Tumor Microenvironment and Immune Response in Malignant Melanoma
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
This study collects and stores blood and tumor samples from patients with malignant melanoma and healthy individuals. The purpose of this study is to gain a better understanding of the causes of melanoma and how melanoma tumors behave. Storing blood and tumor samples for future research may lead to new discoveries that may ultimately help with diagnosing or treating this disease.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 13 Sept 2020
- Start date
- 7 May 2013
- Primary completion date
- 31 Oct 2027
- Lead sponsor
- Ohio State University Comprehensive Cancer Center
- Diseases
- Melanoma, Childhood cancers
- NCT number
- NCT04567706
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 7 May 2013 to the primary completion date, 31 Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Incarcerated individuals will be excluded from this protocol
Who the study is looking for
- Patient with malignant melanoma or personal history of melanoma
- Normal donors
- Informed consent can be obtained
- Patients with any stage of malignant melanoma
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ohio State University Comprehensive Cancer Center Coordinator of this site? Confirm its status | Columbus | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.